If you have been treated with Acthar, we want to hear from you.
Questcor Pharmaceuticals  is interested in interviewing people who have been treated with Acthar to help lower proteinuria  caused by nephrotic syndrome . These stories will be part of patient and media outreach efforts to help increase awareness about the condition and help other patients better understand their treatment options. We would like to invite you to be one of those interviewed. Please note, not all applicants' stories will be used in outreach efforts.
The interview will be conducted over the phone by a representative of Questcor. He or she will ask you to describe your experience concerning the use of Acthar to treat your proteinuria due to nephrotic syndrome. If you are willing to share your experience, please complete the form below and a representative of Questcor will contact you. Your contact information will not be distributed or sold, and your story will not be shared without your written consent.
(Please fill out the form completely before submitting.)
* All required fields
H.P. Acthar® Gel and Questcor® are registered trademarks of Questcor Pharmaceuticals, Inc.